Fingerprint
Dive into the research topics of 'An open-label, dose-ranging trial of AL 721 in patients with persistent generalized lymphadenopathy and AIDS-related complex'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
An open-label, dose-ranging trial of AL 721 in patients with persistent generalized lymphadenopathy and AIDS-related complex
Donna Mildvan, Jeffrey Buzas, Donald Armstrong, Diana Antoniskis, Henry S. Sacks, Frank S. Rhame, Erwin W. Mosbach, Carla Pettinelli
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations